Jeffrey M. Leiden, Executive Chairman: Vertex Pharmaceuticals VRTX Sell · Filed 23/12/15

Trade details

Type: Insider sale
Amount: $5,293,780.14
Shares · price: 13,254 sh · $399.41 a share
Held after: 9,171 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Jeffrey M. LeidenExecutive Chairman
Trade date: 23/12/13
Filed: 23/12/15
Days to filing: 2 days

Sold 59.1% of holdings

Share of holding sold: 59.1%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/11/13~24/01/12

Jeffrey M. Leiden's recent trades

Jeffrey M. LeidenDirector
BuyOdyssey Therapeutics
Buy
Odyssey Therapeutics
ODTX
$100K
5,000 sh
$100K
Filed 05/11
Traded 05/08
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$7.1M
15,681 sh
$7.1M
Filed 25/12/05
Traded 25/12/03
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$4.7M
10,360 sh
$4.7M
Filed 25/12/05
Traded 25/12/03
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3.5M
7,899 sh
$3.5M
Filed 25/12/05
Traded 25/12/03
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2.6M
5,880 sh
$2.6M
Filed 25/12/05
Traded 25/12/03

Jeffrey M. Leiden, Chairman — sold $5.3M of Vertex Pharmaceuticals VRTX · 59.1% of holdings · 10b5-1 plan | Whalegun